ADGRL3 and breast cancer: Regression analysis of the LPHN3 expression with an IHC index > 4 indicated significance of LPHN3 expression as both a breast cancer prevention biomarker and also for anti-tumor metastasis to axillary lymph nodes (P-value = 0.001) (Table 4).